Breakthrough Algorithms Predict Sudden Cardiac Death Risk AHA in Chicago: GE Healthcare announced this week that it is the only company with two patented algorithms that meet new MN guidelines that help physicians predict whether a patient is at risk for sudden cardiac death (SCD).
If its cancer care, emergency medicine, pediatric and maternal-fetal medicine specialties keep Robert Wood Johnson University Hospital (RWJUH) in New Brunswick at the forefront of nationally recognized hospitals, its heart center is what keeps it pumping.
The Emboshield PRO Embolic Protection System received CE approval and will be launched in Europe. Embolic protection ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
The LATITUDE Patient Management System by Boston Scientific has FDA approval to be used in virtually all of the company ...
RadiForce GS320 (standard model) and GX320 (high-end model) are 3MP monochrome LCD monitors for accurate diagnosis in ...
The first third-generation drug-eluting stent is now available to physicians and patients in many markets around the ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
The FDA gave Humanitarian Device Exemption (HDE) approval for the AbioCor Implantable Replacement Heart (AbioCor). The ...
Diagnosoft, Inc. has received FDA approval for its HARP software that assists physicians in the analysis of magnetic ...
From the AHA exhibit hall this week, GE Healthcare has highlighted new breakthroughs to its Vivid cardiovascular ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Numerous clinical data and physician-led presentations during the TCT meeting in October addressed the important role ...
CoreValve’s patented ReValving System, consisting of an 18-French delivery catheter, was used to percutaneously implant ...
ACC together with AHA and other key healthcare organizations, has launched "Door to Balloon (D2B): An Alliance for Quality." A Guidelines Applied in Practice (GAP) Program, the D2B campaign is aimed at improving the timeliness of lifesaving therapy for patients with heart attacks at the nation's hospitals that perform emergency angioplasty.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Cabrini Medical Center of New York City and University of California, Irvine (UCI) Cardiovascular Imaging Center, have ...
The diagnostic tools are in place, but the connection between imaging machines and data management systems needs to be tighter if cardiovascular practices are going to keep up with the ever-growing patient volume, experts at Siemens Medical Solutions said from the American Heart Association's (AHA) Scientific Sessions.
Medtronic, Inc. has the FDA’s approval to initiate the Feasibility of the Lone Atrial Fibrillation Clinical Trial (FACT) ...
November 15, 2006
